Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.

A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...

First Canadian to receive procedure says she would do it ‘a million times over’ compared with previous work to keep blood ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 diabetes in whom the benefits outweigh the risks of immunosuppression.

Since the 1920s, the standard of care for type 1 diabetes was insulin replacement therapy—requiring millions of Americans to administer insulin via a pump or injection multiple times a day.

The islets’ insulin producers are called beta cells. (Cell types alpha, gamma, delta and epsilon perform other tasks.) They are the only bodily sources of that hormone.

Beta islets, by contrast, produce the glucose-lowering hormone insulin. When beta cells are missing or irreparably impaired, glucose control goes awry, and type 1 diabetes can result.

Type 1 diabetes attacks islet cells, a specialized group of pancreatic cells that produce insulin. VX-880 consists of islet cells grown from embryonic stem cells, which can be nudged to transform ...

It has been hypothesized that allogeneic, hypoimmune (HIP) iPSC-derived or donor-derived islet grafts could provide a new and safe therapeutic alternative for the treatment of type 1 diabetes mellitus ...

Sana Biotechnology’s genetically engineered pancreatic islet cells controlled glucose levels for six months in a diabetic primate without requiring insulin or immunosuppression, according to new ...